Top Markets
Coin of the day
Alpha Cognition Inc Alpha Cognition Inc

Alpha Cognition Inc

ACOG
Rankning i aktier #19835
Alpha Cognition Inc., a biopharmaceutical company, engages in the development... Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer's disease; ALPHA-1062 sublingual formulation for acute pancreatitis; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mild traumatic brain injury; and ALPHA-0602, ALPHA-0702, and ALPHA-0802 programs for the treatment of neurodegenerative diseases, including amyotrophic lateral sclerosis disease and spinal muscular atrophy. The company was founded in 2000 and is headquartered in Vancouver, Canada.
Aktiekurs
$9.61
Senast synkroniserad: 2026-08-25
Marknadsvärde
$149.33M
Förändring (1 dag)
-1.39%
Förändring (1 år)
21.24%
Land
US
Handel Alpha Cognition Inc (ACOG)

Kategori

Historik för aktiesplit för Alpha Cognition Inc (ACOG)
Aktien Alpha Cognition Inc (symbol: ACOG) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Aug 26, 2026.
En ACOG-aktie köpt före Aug 26, 2026 motsvarar nu 0 ACOG-aktier.
Lista över aktiesplitar
År Split Multipel Kumulativ multipel
Inte tillräckligt med data för de angivna datumen.
Aktiesplitar för liknande företag eller konkurrenter
Företag Antal aktiesplitar Kumulativ multipel Land
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH